Henan Lingrui Pharmaceutical Co., Ltd. (600285.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 19.12

From 52W high−16.61%

Volume3.24M

Market capCNY 11.10B

P/E (TTM)14.6x

P/S (TTM)2.7x

Div yield5.76%

Key dataSep 18, 2026

Open

CNY 19.12

From 52W high

−16.61%

Volume

3.24M

Market cap

CNY 11.10B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

10.9x

P/E (TTM)

14.6x

RSI (14)

33.9

MomentumView details →

1D Return

+0.20%

YTD Return

−7.73%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

14.6x

EV/EBITDA

10.9x

EV/Sales

2.7x

P/S (TTM)

2.7x

P/B (TTM)

3.4x

ProfitabilityView details →

Gross Margin

80.35%

Net Margin

19.93%

EBITDA Margin

24.89%

ROE (TTM)

21.62%

ROA (TTM)

13.23%

Asset Turnover

0.68x

GrowthView details →

Revenue YoY

+9.58%

EPS YoY

+4.69%

FCF YoY

−21.94%

Revenue CAGR 3Y

+8.68%

EPS CAGR 3Y

+17.03%

EBITDA YoY

—

MomentumView details →

1D Return

+0.20%

YTD Return

−7.73%

1Y Return

−14.30%

RSI (14)

33.9

vs 50D SMA

−8.67%

vs 200D SMA

−10.53%

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

1.17x

Quick Ratio

0.99x

Div Yield

5.76%

Div Rate

CNY 1.10

Div Growth 1Y

+22.22%

EarningsView details →

EPS (Actual)

CNY 0.44

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

3.96B

Net Income (TTM)

789.02M

Op. CF (TTM)

704.72M

Latest newsMore news →

As of August 20, 2026, more than 30 A-share listed companies disclosed securities firms among their top ten circulating shareholders in their 2026 semi-annual reports, with some firms increasing stakes and others newly appearing.31d ago

Lingrui Pharmaceutical disclosed its semi-annual report on August 11, reporting revenue of 2.148 billion yuan, up 2.32% year-on-year, and net profit attributable to shareholders of 495 million yuan, up 4.36% year-on-year.40d ago

Similar companies

Elanco Animal Health IncorporatedELAN Consun Pharmaceutical Group Limited01681.HK XD国药现600420.SH 微芯生物688321.SH Ab&B Bio Tech Co Ltd.02627.HK 康恩贝600572.SH Find similar companies →

Latest newsMore news →

As of August 20, 2026, more than 30 A-share listed companies disclosed securities firms among their top ten circulating shareholders in their 2026 semi-annual reports, with some firms increasing stakes and others newly appearing.31d ago Lingrui Pharmaceutical disclosed its semi-annual report on August 11, reporting revenue of 2.148 billion yuan, up 2.32% year-on-year, and net profit attributable to shareholders of 495 million yuan, up 4.36% year-on-year.40d ago